Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Oyang

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Cancer Communications (London, England)|January 13, 2024
Cellular metabolism: A key player in cancer ferroptosisXianjie Jiang, Qiu Peng, Mingjing Peng, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 2, 2025
Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potentialYaqian Han, Shizhen Li, Linda Oyang, et al.
Frontiers in Oncology|May 16, 2020
RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung CancerShiming Tan, Pin Yi, Heran Wang, et al.
Oncogene|January 8, 2022
The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activityJinguan Lin, Longzheng Xia, Linda Oyang, et al.
Molecular Cancer|July 31, 2024
Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translationXianjie Jiang, Mingjing Peng, Qiang Liu, et al.
Molecular Cancer|January 31, 2025
CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistanceXuemeng Xu, Qiu Peng, Zongyao Ren, et al.
Frontiers in Cell and Developmental Biology|August 14, 2023
Organoids: opportunities and challenges of cancer therapyXianjie Jiang, Linda Oyang, Qiu Peng, et al.
Cell & Bioscience|July 24, 2020
The functions and mechanisms of prefoldin complex and prefoldin-subunitsJiaxin Liang, Longzheng Xia, Linda Oyang, et al.
Frontiers in Oncology|August 8, 2020
Corrigendum: RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung CancerShiming Tan, Pin Yi, Heran Wang, et al.
Frontiers in Oncology|February 9, 2023
The role of tripartite motif-containing 28 in cancer progression and its therapeutic potentialsYiqing Yang, Shiming Tan, Yaqian Han, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Cancer Communications (London, England)|January 13, 2024
Cellular metabolism: A key player in cancer ferroptosisXianjie Jiang, Qiu Peng, Mingjing Peng, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 2, 2025
Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potentialYaqian Han, Shizhen Li, Linda Oyang, et al.
Frontiers in Oncology|May 16, 2020
RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung CancerShiming Tan, Pin Yi, Heran Wang, et al.
Oncogene|January 8, 2022
The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activityJinguan Lin, Longzheng Xia, Linda Oyang, et al.
Molecular Cancer|July 31, 2024
Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translationXianjie Jiang, Mingjing Peng, Qiang Liu, et al.
Molecular Cancer|January 31, 2025
CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistanceXuemeng Xu, Qiu Peng, Zongyao Ren, et al.
Frontiers in Cell and Developmental Biology|August 14, 2023
Organoids: opportunities and challenges of cancer therapyXianjie Jiang, Linda Oyang, Qiu Peng, et al.
Cell & Bioscience|July 24, 2020
The functions and mechanisms of prefoldin complex and prefoldin-subunitsJiaxin Liang, Longzheng Xia, Linda Oyang, et al.
Frontiers in Oncology|August 8, 2020
Corrigendum: RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung CancerShiming Tan, Pin Yi, Heran Wang, et al.
Frontiers in Oncology|February 9, 2023
The role of tripartite motif-containing 28 in cancer progression and its therapeutic potentialsYiqing Yang, Shiming Tan, Yaqian Han, et al.
Pageof 5